Our Difference

...the current model of delivery doesn't work. This sort of technology must be exported to the community, not the other way around. Taking patients out of their supportive environment does not work.

William S Dalton, MD, PHD,
Chief Executive Officer and Center Director of the
H. Lee Moffitt Cancer Center and Research Institute

OncInsights™ is a medical information service that combines the power of cutting edge bioinformatics tools with global disease insights to organize ever expanding drug, disease, and molecular knowledge.

OncInsights extends the breadth of actionable information provided to our oncology partners in support of their treatment decisions with four key advantages:

Community Focus
Scientifically advanced information to support oncologists in selecting the right drug at the right time in their community
Unique, Dynamic Approach
An open system that takes advantage of the most up-to-date information and resources by:
- Concentrating on the molecular basis of the disease, not simply the specific cancer type
- Employing a complete genomic approach exploring more than 20,000 of the molecular attributes of the disease, compared to less than 20 attributes most other services offer
- Screening each patient’s complete cancer profile against a constantly growing catalog of 182 FDA-approved, molecularly targeted drugs, not the dozen or so limited choices offered by other services
- Applying multiple analytic methods that are continuously improved for optimal information value, not relying on a single, static method
Quality Assurance
A tumor sample testing process that delivers highly accurate genomic results by:
- Leveraging Affymetrix’s® industry-leading profiling system (genomic microarray platform)
- Adhering to CAP (College of American Pathologists) standards and CLIA (Clinical Laboratory Improvement Amendments) regulations for processing the tissue
Quick, Actionable Reports
Interactive report including support information that is clear, dynamic, interrogable, and actionable